Research News and Research

RSS

Research shows how remdesivir inhibits SARS-CoV-2 replication

In a recent bioRxiv preprint, a research team from Germany, Goran Kokic et al. study the molecular mechanism of remdesivir-induced stalling of RdRp - using synthetic RNA chemistry, biochemistry, and cryo-electron microscopy.

2 Nov 2020

5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro

Researchers tested 5-amino levulinic acid in vitro in human-derived cells and found it prevents severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Because it is safe and ubiquitous in plants and animals, it could be a potential drug against SARS-CoV-2.

1 Nov 2020

Drug used to control blood pressure may improve cancer patients’ response to immunotherapy

The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive.

30 Oct 2020

First-of-its-kind synthetic DNA vaccine designed against Powassan virus

Scientists at The Wistar Institute have designed and tested the first-of-its-kind synthetic DNA vaccine against Powassan virus (POWV), targeting portions of the virus envelope protein.

30 Oct 2020

Researchers seek to understand HIV-related attitudes of nursing faculty in six countries

Since the earliest study about nursing faculty and students attitudes and beliefs about caring for people living with HIV/AIDS (PLHIV) in the early 1990's, there have only been 17 additional studies. Knowledge in this area of study is still lacking to fill some gaps in understanding attitudes towards people living with the disease.

30 Oct 2020

Potential treatment might make tumors more responsive to immunotherapy

Cancer immunotherapies, which empower patients' immune systems to eliminate tumors, are revolutionizing cancer treatment. Many patients respond well to these treatments, sometimes experiencing long-lasting remissions.

30 Oct 2020

Glucose-lowering drugs have neutral effect on mortality, adverse outcomes in COVID-19 patients with type 2 diabetes

In a preprint paper, "Impact of Glucose-Lowering Drugs on Mortality and Other Adverse Outcomes in Patients with Type 2 Diabetes Admitted for COVID-19," researchers conclude a neutral effect on mortality and other adverse outcomes.

30 Oct 2020

Mobile smartphone technology may be key to improving out-of-hospital cardiac arrest survival

Mobile smartphone technology can accelerate first responder dispatch and may be instrumental to improving out of hospital cardiac arrest (OCHA) survival.

30 Oct 2020

Researchers report a novel approach to generate T-cells faster

Adoptively transferred T-cells can prolong survival and sometimes cure patients with advanced solid tumors. While promising, it can take months to generate the necessary T-cells to help these patients. Such slow speed makes this therapy impractical for most patients who need immediate treatment.

30 Oct 2020

Princeton professor selected to receive new award recognizing faculty innovation

Robert Prud'homme, professor of chemical and biological engineering at Princeton University, has been selected to receive the inaugural Dean for Research Award for Distinguished Innovation for the invention of flash nanoprecipitation, a method for creating nanoparticles that promises to improve the delivery of drugs throughout the body.

30 Oct 2020

COVID-19 spreads faster and more widely in U.S. households, finds study

COVID-19 spreads faster and more widely throughout U.S. households than previously reported, according to new preliminary research from a multicenter study led by Vanderbilt University Medical Center researchers and published in MMWR, a weekly report from the Centers for Disease Control and Prevention.

30 Oct 2020

Collective impact partnership models help address critical gaps in health care workforce

Currently, approximately 1.6 million Virginians live in primary care shortage areas and 2.2 million in mental health care shortage areas (Kaiser Family Foundation, 2019), yet only three percent of Virginia's high school career and technical education courses are in the health sciences.

30 Oct 2020

Terror groups exploit the mayhem during COVID-19 for spinning a plethora of sinister schemes

The uncertainty and confusion caused by the COVID-19 pandemic is being "widely exploited by terror groups for spinning a plethora of sinister schemes", which could lead to a new tide of violence against people and governments.

30 Oct 2020

Washing hands and Halloween candy can reduce COVID-19 exposure risk

New research shows that COVID-19 exposure risk from contaminated candy could be successfully mitigated both by washing hands and washing candy using a simple at-home method. A team of researchers published this work today in mSystems, an open-access journal of the American Society for Microbiology.

30 Oct 2020

Study identifies new cause of inflammation in people living with HIV

While current antiretroviral treatments for HIV are highly effective, data has shown that people living with HIV appear to experience accelerated aging and have shorter lifespans - by up to five to 10 years - compared to people without HIV.

30 Oct 2020

University of Illinois Urbana-Champaign professor wins $4.5 million for breast cancer research and therapy

University of Illinois Urbana-Champaign Professor of Molecular and Integrative Physiology Erik Nelson has won a $4.5M Era of Hope Scholar Award from the United States Department of Defense (DoD) Breast Cancer Research Program (BCRP).

30 Oct 2020

Children with minor perinatal brain bleeds have normal cognitive development at two years of age

In 2007, UNC researchers published unexpected and surprising results from a study based on magnetic resonance imaging (MRI) of newborn brains.

30 Oct 2020

Cancer patients, clinicians benefit when symptoms are reported using a electronic real-time system

Both cancer patients and their medical teams found it beneficial when patients shared their symptoms in real time using a web- or telephone-based reporting system, according to a national multi-institutional study.

30 Oct 2020

A $200 debit card won’t do much for seniors’ drug costs

If they've been listening to President Donald Trump, seniors may be expecting a $200 debit card in the mail any day now to help them pay for prescription drugs.

30 Oct 2020

UIC enrolls people into phase 3 monoclonal antibody clinical trial

Researchers at the University of Illinois Chicago are now enrolling people into a phase 3 clinical trial that will test if a monoclonal antibody treatment -- administered as a series of four shots -- will help protect uninfected individuals from acquiring or getting sick from COVID-19 after someone in the household tests positive for COVID-19.

30 Oct 2020

Research News and Research

Research shows how remdesivir inhibits SARS-CoV-2 replication

5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro

Drug used to control blood pressure may improve cancer patients’ response to immunotherapy

First-of-its-kind synthetic DNA vaccine designed against Powassan virus

Researchers seek to understand HIV-related attitudes of nursing faculty in six countries

Potential treatment might make tumors more responsive to immunotherapy

Glucose-lowering drugs have neutral effect on mortality, adverse outcomes in COVID-19 patients with type 2 diabetes

Mobile smartphone technology may be key to improving out-of-hospital cardiac arrest survival

Researchers report a novel approach to generate T-cells faster

Princeton professor selected to receive new award recognizing faculty innovation

COVID-19 spreads faster and more widely in U.S. households, finds study

Collective impact partnership models help address critical gaps in health care workforce

Terror groups exploit the mayhem during COVID-19 for spinning a plethora of sinister schemes

Washing hands and Halloween candy can reduce COVID-19 exposure risk

Study identifies new cause of inflammation in people living with HIV

University of Illinois Urbana-Champaign professor wins $4.5 million for breast cancer research and therapy

Children with minor perinatal brain bleeds have normal cognitive development at two years of age

Cancer patients, clinicians benefit when symptoms are reported using a electronic real-time system

A $200 debit card won’t do much for seniors’ drug costs

UIC enrolls people into phase 3 monoclonal antibody clinical trial

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Event guide: 2nd World RNA-Based Therapeutics & Vaccines Summit Korea

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery